Differential splicing-in of a proline-rich exon converts αNAC into a muscle-specific transcription factor

Genes and Development

Volumn 10, Issue 14, 1996, Pages 1763-1772

  Yotov, Wagner V ^a,c   St Arnaud, René ^b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

myoblast differentiation; myoglobin expression; Transcription

Indexed keywords

HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL FUSION; DNA BINDING; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; MEMBRANE FUSION; MYOTUBE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; RNA SPLICING; SITE DIRECTED MUTAGENESIS;

MURINAE;

EID: 0029784285     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.14.1763     Document Type: Article

References (47)

1. Bassel-Duby, R., M.D. Hernandez, M.A. Gonzalez, J.K. Krueger, and R.S. Williams. 1992. A 40-kilodalton protein binds specifically to an upstream sequence element essential for muscle-specific transcription of the human myoglobin promoter. Mol. Cell. Biol. 12:5024-5032.
2. Bassel-Duby, R., M.D. Hernandez, Q. Yang, J.M. Rochelle, M.F. Seldin, and R.S. Williams. 1994. Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes. Mol. Cell. Biol. 14:4596-4605.
3. Blackwell, T.K. and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110.
4. Blanchetot, A., M. Price, and A.J. Jeffrey. 1986. The mouse myoglobin gene. fur. J. Biochem. 159:469-474.
5. 2+ -ATPase isoform PMCA1c is associated with cell fusion in C2 myocytes. J. Neurochem. 62: 799-802.
6. Candeliere, G.A., P.W. Jurutka, M.R. Haussler, and R. St-Arnaud. 1996. A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol. Cell. Biol. 16:584-592.
7. Courey, A.J. and R. Tjian. 1988. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55:887-898.
8. Crescenzi, M., D.H. Crouch, and F. Tatò. 1994. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: Mechanisms of phenotypic correction in mixed culture with normal cells. J. Cell Biol. 125:1137-1145.
9. Daniels, K.J. and A. Sandra. 1990. Cytoskelctal organization and synthesis in substrate-independent and -dependent myogenesis in chick embryos. Anat. Rec. 227:254-263.
10. Dickson, G., D. Peck, S.E. Moore, C.H. Barton, and F.S. Walsh. 1990. Enhanced myogenesis in NCAM-transfected myoblasts. Nature 344:348-351.
11. Glass, C.K., J.M. Holloway, O.V. Devary, and M.G. Rosenfeld. 1988. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313-323.
12. Gossett, L.A., D.J. Kelvin, E.A. Sternberg, and E.N. Olson. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022-5033.
13. Grayson, J., R.S. Williams, Y.-T. Yu, and R. Bassel-Duby. 1995. Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol. Cell. Biol. 15:1870-1878.
14. Heizmann, C.W. and W. Hunziker. 1991. Intracellular calcium-binding proteins: More sites than insights. Trends Biochem. Sci. 16:98-103.
15. Hu, G.-Z. and H. Ronne. 1994. Yeast BTF3 protein is encoded by duplicated genes and inhibits the expression of some genes in vivo. Nucleic Acids Res. 22:2740-2743.
16. Knudsen, K.A. and A.F. Horowitz. 1977. Tandem events in myoblast fusion. Dev. Biol. 58:328-338.
17. Knudsen, K.A., S.A. McElwee, and L. Myers. 1990a. A role for the neural cell adhesion molecule, N-CAM, in myoblast interaction during myogenesis. Dev. Biol. 138:159-168.
18. 2+ dependent adhesion molecule, N-cadherin, in myoblast interaction during myogenesis. Exp. Cell Res. 188: 175-184.
19. Lassar, A.B., R.L. Davis, W.E. Wright, T. Kadesch, C. Murre, A. Vovonova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic bHLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
20. Lin, Z.X., J.R. Eshelman, S. Forry-Schaudies, S. Duran, J.L. Lessard, and H. Holtzer. 1987. Sequential disassembly of myofibrils induced by myristate acetate in cultured myotubes. J. Cell Biol. 105:1365-1376.
21. Lüscher, B. and R.N. Eisenman. 1990. New light on myc and myb. Part I. Myc. Genes & Dev. 4:2025-2035.
22. Martin, J.F., J.M. Miano, C.M. Hustad, N.G. Copeland, N.A. Jenkins, and E.N. Olson. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647-1656.
23. Mermod, N., E.A. O'Neill, T.J. Kelly, and R. Tjian. 1989. The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain. Cell 58:741-753.
24. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
25. Murre, C., P.S. McCaw, H. Vaessin, M. Caudy, L.Y. Jan, J.N. Yan, C.V. Cabrera, J.N. Buskin, S.D. Hauschka, A.B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
26. Nadal-Ginard, B., C.W.J. Smith, J.G. Patton, and R.E. Breitbart. 1991. Alternative splicing is an efficient mechanism for the generation of protein diversity: Contractile protein genes as a model system. Adv. Enzyme Regul. 31:261-286.
27. Ochman, H., A.S. Gerber, and D.L. Hartl. 1988. Genetic applications of an inverse polymerase chain reaction. Genetics 120:621-623.
28. Olson, E.N. and W.H. Klein. 1994. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes & Dev. 8:1-8.
29. Olson, E.N., M. Perry, and R.A. Schulz. 1995. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 172:2-14.
30. Parsons, W.J., J.A. Richardson, K.H. Graves, R.S. Williams, and R.W. Moreadith. 1993. Gradients of transgene expression directed by the human myoglobin promoter in the developing mouse heart. Proc. Natl. Acad. Sci. 90:1726-1730.
31. Parthun, M.R., D.A. Mangus, and J.A. Jaehning. 1992. The EGD1 product, a yeast homolog of human BTF3, may be involved in GAL4 DNA binding. Mol Cell. Biol. 12:5683-5689.
32. Powers, T. and P. Walter. 1996. The nascent polypeptide-associated complex modulates interactions between the signal recognition particle and the ribosome. Cun. Biol. 6:331-338.
33. Rosen, G.D., J.R. Sanes, R. LaChance, J.M. Cunningham, J. Roman, and D.C. Dean. 1992. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell 69:1107-1119.
34. Rudnicki, M.A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
35. Sambrook, J, E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Shore, P. and D. Sharrocks. 1995. The MADS-box family of transcription factors, fur. J. Biochem. 229:1-13.
37. St-Arnaud, R. and J.M. Moir. 1993. Wnt-1 inducing factor-1: A novel G/C box-binding transcription factor regulating the expression of Wnt-1 during neuroectodermal differentiation. Mol. Cell. Biol. 13:1590-1598.
38. St-Arnaud, R., J. Prud'homme, C. Leung-Hagesteijn, and S. Dedhar. 1995. Constitutive expression of calreticulin in osteoblasts inhibits mineralization. J. Cell Biol. 131:1351-1359.
39. Taylor, S.M. and P.A. Jones. 1979. Multiple new phenotypes induced in 10T 1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
40. Wakelam, M.J.O. 1985. The fusion of myoblasts. Biochem. J. 228:1-12.
41. Weintraub, H., V.J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S.J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes & Dev. 5:1377-1386.
42. Weller, P.A., M. Price, H. Isenberg, Y.H. Edwards, and A.J. Jeffreys. 1986. Myoglobin expression: Early induction and subsequent modulation of myoglobin and myoglobin mRNA during myogenesis. Mol. Cell. Biol. 6:4539-4547.
43. Wiedmann, B., H. Sakai, T.A. Davis, and M. Wiedmann. 1994. A protein complex required for signal-sequence-specific sorting and translocation. Nature 370:434-440.
44. Williams, T. and R. Tjian. 1991. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes & Dev. 5:670-682.
45. Yagami-Hiromasa, T., T. Sato, T. Kurisaki, K. Kamijo, Y.-I. Nabeshima, and A. Fujisawa-Sehara. 1995. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377:652-656.
46. Yu, Y.-T., R.E. Breitbart, L.B. Smoot, Y. Lee, V. Mahdavi, and B. Nadal-Ginard. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes & Dev. 6:1783-1798.
47. Zheng, X.M., D. Black, P. Chambon, and J.M. Egly. 1990. Sequencing and expression of complementary DNA for the general transcription factor BTF3. Nature 344:556-559.